Editas Medicine (EDIT) Amortization of Deferred Charges (2015)

Editas Medicine's (EDIT) quarterly Amortization of Deferred Charges came in at $17000.0 in Q3 2015, up 13.33% on a QoQ basis from $15000.0 in Q2 2015.

Editas Medicine (EDIT) Amortization of Deferred Charges (2015) Analysis & Trends

Editas Medicine (EDIT) has 1 years of Amortization of Deferred Charges data on file, last reported at $17000.0 in Q3 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Editas Medicine 245.95 Mn 99.30 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2015 17,000.00
Sep 30, 2015 17,000.00
Jun 30, 2015 15,000.00
Jun 30, 2015 15,000.00
Mar 31, 2015 13,000.00
Mar 31, 2015 13,000.00